- Home
- TKO vs ITCI Comparison
TKO vs ITCI Comparison
Compare TKO & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKO
- ITCI
- Stock Information
- Founded
- TKO 1980
- ITCI 2002
- Country
- TKO United States
- ITCI United States
- Employees
- TKO N/A
- ITCI N/A
- Industry
- TKO
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- TKO
- ITCI Health Care
- Exchange
- TKO Nasdaq
- ITCI Nasdaq
- Market Cap
- TKO 13.1B
- ITCI 13.5B
- IPO Year
- TKO N/A
- ITCI N/A
- Fundamental
- Price
- TKO $158.83
- ITCI $128.60
- Analyst Decision
- TKO Strong Buy
- ITCI Buy
- Analyst Count
- TKO 14
- ITCI 13
- Target Price
- TKO $146.46
- ITCI $103.92
- AVG Volume (30 Days)
- TKO 1.3M
- ITCI 2.2M
- Earning Date
- TKO 02-26-2025
- ITCI 02-21-2025
- Dividend Yield
- TKO N/A
- ITCI N/A
- EPS Growth
- TKO N/A
- ITCI N/A
- EPS
- TKO N/A
- ITCI N/A
- Revenue
- TKO $2,776,140,000.00
- ITCI $680,852,000.00
- Revenue This Year
- TKO $66.87
- ITCI $48.28
- Revenue Next Year
- TKO $15.42
- ITCI $37.34
- P/E Ratio
- TKO N/A
- ITCI N/A
- Revenue Growth
- TKO 108.30
- ITCI 46.62
- 52 Week Low
- TKO $78.69
- ITCI $63.30
- 52 Week High
- TKO $179.09
- ITCI $128.77
- Technical
- Relative Strength Index (RSI)
- TKO 47.78
- ITCI 83.90
- Support Level
- TKO $152.58
- ITCI $126.88
- Resistance Level
- TKO $179.09
- ITCI $128.19
- Average True Range (ATR)
- TKO 5.85
- ITCI 0.41
- MACD
- TKO -1.29
- ITCI -1.30
- Stochastic Oscillator
- TKO 23.58
- ITCI 91.01
About TKO TKO Group Holdings Inc.
TKO Group Holdings Inc is a premium sports and entertainment company that comprises UFC, the world's mixed martial arts organization, and WWE, an integrated media organization and the recognized leader in sports entertainment.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.